11月 2025
- 首頁
- Aprecia Pharmaceuticals
11月 2025Aprecia Pharmaceuticals的市場佔有率分析
With our patient focused innovation, Aprecia provides a new spectrum of possibilities of 3DP- enabled formulation platforms assisting patients to live better, healthier lives. Get started with us today.
Aprecia Pharmaceuticals(包含公司地區)
查看更多網站流量與參與度資訊- aprecia.com
Aprecia Pharmaceuticals截至 11月 2025 的總收入為 25M - 50M
Aprecia Pharmaceuticals 熱門網域產生的總收入
Aprecia Pharmaceuticals 熱門網域 3 年內的總收入
Aprecia Pharmaceuticals 熱門網域的總收入
Aprecia Pharmaceuticals的熱門網域總造訪量
了解Aprecia Pharmaceuticals市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Aprecia Pharmaceuticals的熱門網域平均造訪時長
分析Aprecia Pharmaceuticals參與度指標。
過去 3 個月平均造訪時長
子公司細目
Aprecia Pharmaceuticals的熱門網域平均頁面瀏覽量
了解Aprecia Pharmaceuticals如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Aprecia Pharmaceuticals
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Aprecia Pharmaceuticals Company partners with MIT.The first real-world success came from the United States, where Aprecia Pharmaceuticals, in collaboration with the Massachusetts Institute of Technology (MIT), developed Spritam (levetiracetam).
11月 19, 2025閱讀更多
新聞Aprecia Pharmaceuticals Company partners with Department of Health and Human Services.Battelle and Aprecia collaborate with U.S. Department of Health and Human Services (HHS) and U.S. Defense Advanced Research Projects Agency (DARPA) to advance U.S. Drug manufacturing capability utilizing 3d-printed technology to produce essential medicines at the point of need.
8月 19, 2025閱讀更多
新聞Aprecia Pharmaceuticals Company signs new client Defense Advanced Research Project Agency.Battelle, a global research and development organization, and Aprecia, a pharmaceutical manufacturing company, have been awarded a US Defense Advanced Research Projects Agency (DARPA) agreement to advance the Establishing Qualification Processes for Agile Pharmaceutical Manufacturing (EQUIP-A-Pharma) program.
8月 19, 2025閱讀更多
查看所有Aprecia Pharmaceuticals信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。